Lori Anne Kunkel insider trades

Open-market stock purchases and sales by Lori Anne Kunkel, Unknown at Enliven Therapeutics, Inc, from SEC Form 4 filings since Dec 1, 2011.

Recent trades

DateStockTradeValue
Jul 6, 2026ELVN Enliven Therapeutics, IncSold$299K
Jul 6, 2026ELVN Enliven Therapeutics, IncSold$205K
Jun 5, 2026ELVN Enliven Therapeutics, IncSold$267K
Jun 5, 2026ELVN Enliven Therapeutics, IncSold$66K
Jun 5, 2026ELVN Enliven Therapeutics, IncSold$12.7K
Feb 12, 2026ELVN Enliven Therapeutics, IncBought (not open market)—
Jan 2, 2026ORIC Oric Pharmaceuticals, IncBought (not open market)—
Dec 17, 2025ELVN Enliven Therapeutics, IncBought (not open market)—
Dec 8, 2025ORIC Oric Pharmaceuticals, IncBought (not open market)—
Dec 4, 2025ORIC Oric Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ELVN Enliven Therapeutics, Inc: 5 sales, last Jul 6, 2026
  • ORIC Oric Pharmaceuticals, Inc: other filings, last Jan 2, 2026
  • NRIX Nurix Therapeutics, Inc: other filings, last May 19, 2025
  • CRIS Curis Inc: 1 sale, last Jan 31, 2022
  • TOCA Tocagen Inc: other filings, last Oct 4, 2019
  • LOXO Loxo Oncology, Inc: 15 sales, last Oct 1, 2018
  • PCYC Pharmacyclics Inc: other filings, last Apr 30, 2013

Get free alerts when Lori Anne Kunkel files a new trade →